生命科学资讯

Biotech's 2026 outlook: Six questions for the year ahead

Mirador raises $250M, with plans to become an immunology powerhouse

Genentech CEO says pharmacy benefit manager shift will save $70M

Hair growth biotech Veradermics files for IPO to fund oral Rogaine

US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and more

Eikon Therapeutics files for IPO, testing biotech rally

How Merck plans to set a buffer for Keytruda's patent cliff

Aktis' 25% IPO bounce builds hope for 2026's public offerings

Orca adds $250M in financing to back launch of T cell therapy

Novartis to build fourth US radiotherapy factory in Florida

Venture firm a16z raises $700M; Ribo Life's $230M Hong Kong IPO

BioNTech, UPenn team up for $50M seed fund

Krystal Biotech says it can deliver native protein to cystic fibrosis patients

J&J strikes drug pricing, tariff deal with the White House

Roche returns to Chinese biotech MediLink for another ADC pact

Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News

AirNexis gets $200M to test China-derived COPD drug

Speculation builds about a deal for Revolution Medicines

Medipost gets $140M to take Korean stem cell therapy into US

Gene editing pioneers launch first startup focused on custom CRISPR therapies